Dec 30

LATISSEâ„¢ - New Prescription Product Increases Length, Thickness And Darkness Of Eyelashes (Medical News Today)

post Category: Hyperhidrosis news post post30 December 2008

Allergan, Inc. (NYSE: AGN) today announced the U.S. Food and Drug Administration (FDA) has approved LATISSEâ„¢ (bimatoprost ophthalmic solution) 0.03% as a novel treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes.

Read full story

Related Posts

bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark

« Allergan Announces U.S. Food and Drug Administration (FDA) Approval of LATISSE — First and Only Treatment Approved by … (Business Wire via Yahoo! Finance)
Festive season is no sweat as partygoers go for Botox jabs »

Sorry, no comments yet.

Write Your Comment

Comment Guidelines: Basic XHTML is allowed (a href, strong, em, code). All line breaks and paragraphs will be generated automatically.

You should have a name, right? 
Your email address, I promised I won't tell it to anyone. 
If you have a web site or blog, you can type the URL right here. 
This is where you type your comments. 
Remember my information for the next time I visit.
 

Spam Protection by WP-SpamFree